Article
[Age-related macular degeneration].
Vestnik oftalmologii - 1 Jan 2000
Budzinskaia M V
Abstract excerpt
The review provides an update on the pathogenesis and new treatment modalities for neovascular age-related macular degeneration (AMD). The impact of polymorphism in particular genes, including complement factor H (CFH), age-related maculopathy susceptibility 2 (ARMS2/LOC387715), and serine peptidase (HTRA1), on AMD development is discussed. Clinical presentations of different forms of exudative AMD, that is...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
